ACGT Progenomics

ACGT Progenomics is an established, revenue-generating service provider in the genetics and genomics sector, offering a suite of DNA sequencing technologies including Sanger, Oxford Nanopore long-read, and NGS. The company caters primarily to research institutions, pharmaceutical developers, and sequencing cores, emphasizing GLP/GMP compliance for regulatory submissions. With over 30 years of operation and a recent expansion to the San Francisco Bay Area, ACGT leverages its experience and dedicated customer service to maintain a strong position in the competitive sequencing services market. Its business model is built on fee-for-service contracts, partnerships, and consumable card programs.

Portfolio of DNA sequencing technologies including Sanger sequencing, Oxford Nanopore long-read sequencing for whole plasmids, Next-Generation Sequencing (NGS), and SNP genotyping (TaqMan, Sanger). Supported by bioinformatics and operated under GLP/GMP compliant quality systems.

ACGT competes in a fragmented market with large, diversified CROs (e.g., Eurofins, Charles River), specialized sequencing service providers, and in-house academic core facilities. Its key differentiators are its long-standing reputation, focus on regulatory compliance (GLP/GMP), and personalized customer service. However, it lacks the scale and brand recognition of the largest global players.